mechanical ventilation, reducing bacterial colonization of aerodigestive tract, minimizing secretions above cuff with the use cuffed ETT with inline or subglottic suctioning, preventing contamination of lower airway, and preventing exposure to contaminated equipment. The purpose of the current study was to assess the effectiveness of subglottic suctioning for prevention of VAP.
PAtIents And methods
This was a prospective, interventional, cross-sectional study. Patients in the age group between 15 and 85 years admitted to the ICU from October 2014 to June 2016 who developed VAP after receiving mechanical ventilation (fulfilling criteria of VAP definition as per Centre for Disease Control and Prevention) were enrolled in the study. The study was started after the approval of Ethics Committee. The study population was from both rural and urban areas near the hospital and was from all socioeconomic classes.
The patients were randomly divided into two groups: Group No subglottic secretion drainage (NSSD) where they were intubated with ETT of Portex ® brand without provision of suction above cuff and Group Continuous subglottic secretion drainage (CSSD) where ETT of Portex ® brand with provision of suction above cuff was used.
Patients with acute myocardial infarction or unstable angina, cardiac arrhythmias, refractory hypoxemia, pulmonary hypertension, lung abscess, hemodynamically unstable patients, requirement of high levels of positive end-expiratory pressure, cultures showing growth of fungus, and patients referred from another hospital diagnosed as VAP were excluded from the study.
A total of 220 critically ill patients were enrolled in this period, 120 patients in NSSD group and 100 in the CSSD group. Fifty patients in each group developed VAP on follow-up. Thus, the total population in this study was 100.
The ETT cuff pressure was maintained in a range of 18-24 cmH 2 O and was regularly monitored in both groups. Continuous subglottic suctioning was accomplished with a special ETT with a suction port in the dorsal lumen that resides just above the inflated balloon. This permits aspiration of secretions in the subglottic space, [13, 14] thus preventing pooling of these secretions above inflated cuff which could lead to aspiration.
Subglottic secretions were collected under strict aseptic precautions into mucous extractor using a suction pressure of 20-30 cmH 2 O and were immediately transported to the laboratory for microbiological examination (for aerobic bacterial culture).
Bronchoalveolar lavage fluid (BALF) specimens were collected under strict aseptic precautions using Olympus BF 180 series fiber-optic bronchoscope. A volume of 50-200 mL of sterile saline was infused into the distal bronchoalveolar tree. Subsequently, suctioning was done and immediately transported to the laboratory for microbiological examination (for aerobic bacterial culture). Both the subglottic and BALF samples were collected at the same time and were subjected to microbiology laboratory within half an hour for culture and identification of microorganisms. The samples were inoculated on blood agar and MacConkey's agar and incubated for a period of 48-72 h for the growth of the bacteria. The colony morphology was studied. Preliminary identification tests such as Gram stain, motility, catalase, and oxidase test were performed. The samples were then subjected for aerobic bacterial cultures. Identification of the bacteria was done by the card (Gram-positive and Gram-negative) of VITEK-2 compact (vio Merieux).
Data of continuous variables were reported as means ± standard deviation whereas categorical data were expressed as percentages or frequency tables. Correlation analysis was done to evaluate the association between various measured variables. Student's t-test was used to compare the incidence of VAP in both groups. Odds ratio was calculated using Chi-square test, from which relative risk reduction was estimated. A value of P < 0.05 was considered to be statistically significant. All statistical analyses were done using SPSS version 17.0, IBM Computers (SPSS Inc. Released 2008. SPSS Statistics for Windows, Version 17.0. Chicago).
Results
The mean age of the patients was 56 ± 13 years. Fifty-eight patients were males. The incidence of VAP among NSSD group was 41.7% and in CSSD group was 25% [ Table 1 ]. The odds ratio was 0.467 (confidence interval: 0.28, 0.75) with a relative risk reduction of 0.39.
Among the various comorbidities, hypertension (28.57%) was the most common and seizure disorder (1.68%), the least. Other comorbidities are mentioned in Table 2 . Respiratory failure (type 1 and type 2) and airway protection were the two reasons for intubation, Type 2 respiratory failure was seen in 90% of patients in the NSSD group and 82% of patients in CSSD group. Majority of the patients were suffering from chronic obstructive pulmonary disease (COPD) and presented with acute exacerbation of underlying COPD.
The most common microorganisms among the patients who were diagnosed with early onset VAP (EOVAP) was Klebsiella pneumoniae (43%). Among the patients with late onset VAP (LOVAP), Acinetobacter baumannii was the most common (30%). The most common microorganism in the NSSD group was K. pneumoniae (44%), and in CSSD group, A. baumannii (32%). The prevalence of various other microorganisms as a causative agent in this study population is depicted in Table 3 . The coefficient of correlation for the microorganisms cultured from subglottic and BALF in each group was calculated using Pearson's correlation. In the total study population, the correlation coefficient was 0.78 (P = 0.01). In the NSSD group, the correlation coefficient was 0.82 (P = 0.01). In the CSSD group, correlation coefficient was 0.76 (P = 0.01).
The average number of days of mechanical ventilation at the time of VAP diagnosis was more in CSSD group with 5.82 ± 0.69 days, whereas, in NSSD group, VAP was diagnosed within 3.62 ± 0.67 days (P = 0.0001). The average duration of mechanical ventilator support in CSSD group was 7.8 ± 1.03 days compared to 10.5 ± 1.18 days in the NSSD group (P = 0.0001). The mean ICU stay was also higher in the NSSD group (12.9 ± 1.84 days) compared to CSSD group (9.2 ± 1.17 days) (P = 0.0001) [ Table 4 ].
dIscussIon
VAP is a prevalent and costly nosocomial infection related to instrumentation of the airway with an ETT, enabling microaspiration of contaminated secretions.
In our study, the incidence of VAP in NSSD group was 41.66% and in the CSSD group was 25%. Compared to study done by Ranjan et al., overall incidence of VAP was 57.14%. [15] The lower incidence in the present study may be due to differences in study population, definition of VAP itself (clinically vs. microbiologically oriented) and possibly, to the use of preventive strategies.
The 39% relative risk reduction in the incidence of VAP was significant with the adoption of subglottic suction ETTs. The proportion of EOVAP (47%) and LOVAP (53%) was similar to that in the study by Golia et al. [16] In their study, 44.23% had EOVAP and 55.77%, LOVAP.
Among other factors, age is an important factor. As age increases, the immune response and mucociliary clearance decrease increasing the susceptibility for VAP development. Bonten et al. found that age >60 years was a nonmodifiable risk factor with an odds ratio of 5.1. [17] In our study, the mean age group was 56 ± 13 years. VAP also has a male preponderance as seen by Jaimes et al. [18] (58%) and Huang et al. [19] (67%) of VAP patients.
The incidence of comorbidities is similar to that seen in the study by Huang et al. with hypertension being the most common (28.57%) followed by diabetes mellitus (20.16%) and chronic kidney disease 7.56%. [20] The onset of VAP was delayed in the CSSD group by 5.82 ± 0.69 days versus NSSD group by 3.62 ± 0.67 days. These findings are similar to that of Yang et al. [20] Patients with continuous aspiration of subglottic secretions had delayed onset of VAP (7.3 ± 4.2 days) as compared to No aspiration of subglottic secretions (5.1 ± 3.0 days) (P = 0.100).
In another randomized study that included 714 patients undergoing cardiac surgery, subglottic secretions removal demonstrated a significant reduction in the incidence of VAP, ICU length of stay, antibiotic use, and overall mortality. [11] In our study, the length of ICU stay in CSSD In the study conducted by Ahmed A Alsaddique, the use of continuous subglottic suction was beneficial even in the case of established VAP. It prevents further soiling of the airways, hastens recovery, and shortens the ICU stay. They suggested that subglottic suction is instituted early in case of prolonged mechanical ventilation to prevent VAP. [21] The most common microorganism cultured from BALF was K. pneumoniae followed by A. baumannii in the current study. Ranjan et al. identified A. baumannii followed by Pseudomonas aeruginosa were the most common microorganisms in their study. [15] In our study, the microorganisms cultured in EOVAP was K. pneumoniae most common followed by A. baumannii in EOVAP, but it was reversed in LOVAP. Golia et al. isolated P. aeruginosa, Escherichia coli, and A. baumannii in EOVAP and LOVAP. [16] Colonization of the oropharynx is an independent predictor for tracheobronchial colonization. Aspiration of these bacteria-containing secretions is the main mechanism of acquiring VAP in mechanically ventilated patients. [22] In our study, the concordance between microorganisms isolated from subglottic and BALF cultures showed that the microorganism present in subglottic secretions might have been microaspirated into lower respiratory tract leading to VAP.
The coefficient of correlation of bacteria cultured from subglottic and BALF of NSSD group was 0.82 (P = 0.01) and that of CSSD group was 0.76 (P = 0.01). This shows that concordance of bacteria in subglottic and BALF is more in NSSD group when compared CSSD group.
conclusIon
The use of continuous subglottic suction reduces the incidence of VAP and the number of days of mechanical ventilation and duration of ICU stay. A greater concordance of organisms grown in subglottic and BALF cultures, when subglottic suction is not used, suggests a reduction of aspiration of subglottic secretions as a factor contributing to VAP when ETTs with subglottic suction are used.
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